Main > ONCOLOGY (**) > Skin Cancer>CSCC>MET Or Locally>> > TREAT.: > USA. RS. CemipliMAb Inj. 350 mg

---

USA. RS. CemipliMAb Inj. 350 mg's subsections
(*) BR Approval Date: ?
(*) CA Approval Date: 2019. 04.10.
(*) EU Approval Date: 2019. 07.01.
(*) USA Approval Date: 2018. 09.28.
>Advanced
>Not Candidates for Surgery or RT
Companies
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2020. 01.07.
TradeMark
TradeMark Web-Site

USA. RS. CemipliMAb Inj. 350 mg's products
This section has no products